![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
01 Dr. Reddy's Laboratories (3)
02 NanoAlvand (2)
03 Naprod Life Sciences (1)
04 Accure Labs (2)
05 Apotex Inc (3)
06 Bluepharma (3)
07 Health Biotech (1)
08 Intas Pharmaceuticals (3)
09 Jodas Expoim Pvt. Ltd (2)
10 Novartis Pharmaceuticals Australia Pty Limited (7)
11 Novartis Pharmaceuticals Corporation (5)
12 Novartis South Africa (Pty) Ltd (2)
13 Pharmacare Premium (1)
14 Sichuan Xieli Pharmaceutical (2)
15 TherDose Pharma (2)
16 Zentiva (2)
01 CAP (2)
02 CAPSULE (6)
03 CAPSULE;ORAL (6)
04 Capsule (8)
05 Capsules (3)
06 Hard Capsule (3)
07 Hard Gelatin Capsule (2)
08 Oral Solid Dosage Form (3)
09 Blank (8)
01 DISCN (3)
02 Generic (6)
03 Lead Market Dossiers- Under Development (3)
04 Originator (2)
05 Prescription (2)
06 RX (3)
07 Blank (22)
01 Lotigna (2)
02 NILOTINIB HYDROCHLORIDE (3)
03 TASIGNA (5)
04 Tasigna (7)
05 Tasigna 150 Mg (1)
06 Tasigna 200 Mg (1)
07 Blank (22)
01 Australia (7)
02 Canada (2)
03 China (2)
04 Czech Republic (2)
05 India (14)
06 Iran (2)
07 Malta (1)
08 Portugal (3)
09 South Africa (2)
10 USA (6)